Catalent | CTLT - L'Utile Ante Imposte



L'Utile Ante Imposte Cambiamento Data
Agilent USD 442M 1000K 2025-09
AstraZeneca USD 3.24B 117M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Bruker USD -72.6M 73.1M 2025-09
Centene USD -6.67B 6.42B 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cigna USD 2.3B 274M 2025-09
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -230M 77M 2025-09
Elevance Health USD 215M 1.19B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Glaxosmithkline GBP 2.46B 569M 2025-09
Humana USD 527M 214M 2025-09
Illumina USD 220M 86M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
IQVIA Holdings USD 537M 5.62B 2025-12
J&J USD 7.82B 2.86B 2026-03
Laboratory Of America USD 337M 32.3M 2025-09
Lonza CHF 624M 197M 2024-12
McKesson USD 1.4B 344M 2025-09
Merck EUR 1.29B 458.1M 2025-09
Merck USD 6.74B 22M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Novartis USD 4.64B 445M 2025-12
Pfizer USD 3.33B 290M 2025-09
Quest Diagnostics USD 330M 6M 2025-12
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
UnitedHealth USD -720M 3.95B 2025-12
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 170.12M 7.57M 2025-09
West Pharmaceutical Services USD 161.5M 8.6M 2025-12